Answer
Tisagenlecleucel (Kymriah) is not recommended during pregnancy or in women of childbearing potential not using contraception, and pregnant women should be advised of potential risks to the foetus.
Sources for this answer
- Kymriah cells dispersion for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 15Document updated
Sources checked